We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Merck plans to acquire cancer drug developer VelosBio for $2.75 Billion, expanding its presence in antibody-drug conjugates (ADCs), a new class of biological drugs. Read More
Dr. Reddy’s Laboratories, one of India’s largest pharmaceutical companies, announced Thursday that it has temporarily shut down all of its data center services in response to a cyberattack. Read More
Novavax announced Wednesday that it has reached an agreement with Australia that will see the company supply 40 million doses of its COVID-19 vaccine candidate for the country. Read More
Sanofi announced that it is acquiring a portfolio of cell immunotherapies under development to treat various cancers through the purchase of Amsterdam-based biopharma Kiadis for $358 million. Read More